however, some systemic effects have also been identified. The proposed theory is that immunoglobulins and glycoproteins exist in plasma products and have the potential to bind with pathogenic bacteria receptors and thus reduce their adhesion to the mucosal wall in the gastrointestinal tract (GIT)